Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 3284 entries
View as:

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

Phase: N/A Priority: Normal
NCT ID: NCT00163410 Org: User:
Start: 04/30/03 End: 12/31/04 Due: 12/31/05

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00777361 Org: User:
Start: 10/31/08 End: 10/31/09 Due: 10/31/10

eVusheld Assessment reaL wORld Effectiveness in the VA Health System

Phase: N/A Priority: Normal
NCT ID: NCT05663957 Org: User:
Start: 01/04/23 End: 09/01/23 Due: 09/01/24

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Phase: N/A Priority: Normal
NCT ID: NCT01866904 Org: User:
Start: 06/19/13 End: 03/31/17 Due: 03/31/18

A Pharmacodynamic Study With Ticagrelor in African American Patients

Phase: N/A Priority: Normal
NCT ID: NCT01523392 Org: User:
Start: 03/31/12 End: 09/30/13 Due: 09/30/14

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Phase: N/A Priority: Normal
NCT ID: NCT00163358 Org: User:
Start: 09/30/03 End: 10/31/05 Due: 10/31/06

Drug Interaction Study Between AZD3480 and Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT00689637 Org: User:
Start: 09/30/07 End: 02/28/09 Due: 02/28/10

Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

Phase: N/A Priority: Normal
NCT ID: NCT01623609 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

Candesartan Effect in Second Stage Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00621153 Org: User:
Start: 02/29/08 End: 03/31/09 Due: 03/31/10

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04214093 Org: User:
Start: 12/16/19 End: 06/18/21 Due: 06/18/22

Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01437540 Org: User:
Start: 09/19/11 End: 04/30/13 Due: 04/30/14

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)

Phase: N/A Priority: Normal
NCT ID: NCT00824057 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02161770 Org: User:
Start: 12/22/14 End: 08/22/17 Due: 08/22/18

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04516746 Org: User:
Start: 08/28/20 End: 02/10/23 Due: 02/10/24

A Feasibility Study to Collect Data in Patients With Haemophilia

Phase: N/A Priority: Normal
NCT ID: NCT00798499 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Phase: N/A Priority: Normal
NCT ID: NCT05826366 Org: User:
Start: 06/02/23 End: 04/30/25 Due: 04/30/26

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT05184062 Org: User:
Start: 12/03/21 End: 05/06/23 Due: 05/06/24

Schizophrenic Patients Taking Part in Integrated Care Program

Phase: N/A Priority: Normal
NCT ID: NCT00617214 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00162305 Org: User:
Start: 04/30/05 End: 08/31/05 Due: 08/31/06

To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01176097 Org: User:
Start: 07/31/10 End: 02/28/11 Due: 02/28/12

A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02712372 Org: User:
Start: 06/30/16 End: 10/31/16 Due: 10/31/17

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594

Phase: N/A Priority: Normal
NCT ID: NCT01636024 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04570657 Org: User:
Start: 09/17/20 End: 02/06/23 Due: 02/06/24

International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study

Phase: N/A Priority: Normal
NCT ID: NCT03078036 Org: User:
Start: 03/13/17 End: 05/20/19 Due: 05/20/20

AZD5423 Multiple Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01037504 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11